1.Predicted Factors of Remission in Graves' Disease.
Journal of Korean Society of Pediatric Endocrinology 2007;12(1):1-5
No abstract available.
Graves Disease*
2.Graves' Disease: Current and Future Directions.
Korean Journal of Endocrine Surgery 2001;1(1):1-5
No abstract available.
Graves Disease*
3.Guillain-Barré syndrome developing in a patient with Graves' disease.
Journal of the ASEAN Federation of Endocrine Societies 2019;34(1):103-106
Graves' disease (GD) and Guillain-Barre syndrome (GBS) are both autoimmune disorders and are triggered by interactions between genetic and environmental factors. GBS in patients who suffer from other autoimmune diseases is rarely reported, and the development of atypical GBS with cranial nerve involvement in a patient with GD has never been previously reported. Herein, we report a patient with GD and a rare form of pharyngo-cervico-brachial variety of GBS.
Graves Disease
4.Current trends in the diagnosis and treatment of Graves' disease in Korea.
Journal of Korean Society of Endocrinology 1992;7(3):216-227
No abstract available.
Diagnosis*
;
Graves Disease*
;
Korea*
5.Genetics of Graves' Disease.
Journal of Korean Society of Endocrinology 2003;18(1):5-11
No abstract available.
Genetics*
;
Graves Disease*
6.A clinical study of Graves' disease in children.
Kee Young PARK ; Ho Kyung CHOI ; Jong Jin SEO ; Young Hun CHUNG
Journal of the Korean Pediatric Society 1991;34(6):812-819
No abstract available.
Child*
;
Graves Disease*
;
Humans
7.Primary hypothyroidism following Graves' disease.
Min Ho SHONG ; Ka Hee YI ; Bo Youn CHO ; Hong Kyu LEE ; Chang Soon KOH ; Hun Ki MIN
Journal of Korean Society of Endocrinology 1991;6(1):68-74
No abstract available.
Graves Disease*
;
Hypothyroidism*
8.Propylthiouracil Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in Graves' Disease.
Bo Mi PARK ; Sook Jung YUN ; Seong Jin KIM ; Seung Chul LEE ; Young Ho WON ; Jee Bum LEE
Korean Journal of Dermatology 2012;50(5):479-480
No abstract available.
Eosinophilia
;
Graves Disease
;
Propylthiouracil
9.The variation of blood biochemical indices before and after treating Basedow’s disease using propyl thiouracyl
Journal of Practical Medicine 2004;480(5):19-21
After a 4 weeks of treatment by propyl thyouracil, the biochemical indices of Basedow disease had changed obviously: triiodothyronin (T3) high level (7.95 ± 1.58 nmol/l before treatment) had increased dramatically (1.98 ± 0.54 nmol/l), total thyroxin (T4) high level (257.56 ± 47.45 nmol/l before treatment) had decreased dramatically (1278.04 ± 10.82 nmol/l). FT4 serum level high level had decreased after treatment. TSF low level before treatment had increased. But after treatment glucose level had increased unsignificantly versus that before. In severe condition blood cholesterol had increased, but in moderate and mild condition, there was no change.
Blood
;
Therapeutics
;
Graves Disease
10.Evaluation of evolution in therapeutics of Basedow’s disease in Endocrinology Centre of Hoa Binh province
Pharmaceutical Journal 2003;326(6):27-29
Studied on 360 patients Basedow in Endocrinology Centre of Hoa Binh province from 1/10/1998-1/10/2000. Results of the study were used by biological statistic with the software SPSS 10.0. Results showed that: Among all samples, 78.89% of patients were effectively treated. All the symptoms (except proptosis) and basic metabolic data were improved. ECG and thyroid ultrasound examination results were also significantly improved. However, the rate of compliance was relatively low. Only 26.11% of patients completed all 3 stages of the clinical trial
Graves Disease
;
Therapeutics
;
Endocrinology
Result Analysis
Print
Save
E-mail